Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating?
Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating? Yahoo Finance
Covered in this story
What has happened since
- Thermo Fisher Scientific is up 38.2% since this was published, 130 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
RBC Capital Markets’s $490 target on $TMO is on the record and being tracked to May 2027 (12-month default), scored on the close that day.
RBC Capital Markets’s track record →Analyst targets on Thermo Fisher Scientific
- Morgan Stanley: $560 → $650 by Jul 2027 · Overweight via GuruFocus
- RBC Capital Markets: $568 → $580 by Jul 2027 via GuruFocus
- Barclays: $568 → $650 by Jul 2027 · Overweight via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $TMO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Thermo Fisher Scientific →Dalsna Finance is currently tracking 50 stories mentioning Thermo Fisher Scientific, the earliest published 23 Jul 2026.
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.